Tool Box for Policy Coherence in Access to Medicines and Local Pharmaceutical Production
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Edition
-
Bericht
- Language
-
Englisch
- Notes
-
Lizenzpflichtig
- Classification
-
Wirtschaft
- Event
-
Veröffentlichung
- (where)
-
Bonn
- (who)
-
GIZ
- (when)
-
2017
- Creator
-
Spennemann, Christoph
- Contributor
-
Heineke, Corinna
United Nations Conference on Trade and Development (UNCTAD)
Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ). Bonn/Eschborn
- URN
-
urn:nbn:de:101:1-201712231045
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Spennemann, Christoph
- Heineke, Corinna
- United Nations Conference on Trade and Development (UNCTAD)
- Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ). Bonn/Eschborn
- GIZ
Time of origin
- 2017
Other Objects (12)
A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia
Individualised Medicines by Pharmaceutical Inkjet Printing onto Orodispersible Films
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Access of high technology medicines in Russia
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries
Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential
Strengthening access to medicines through transparency and accountability
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia
Individualised Medicines by Pharmaceutical Inkjet Printing onto Orodispersible Films
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Access of high technology medicines in Russia
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries
Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential
Strengthening access to medicines through transparency and accountability
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia
Individualised Medicines by Pharmaceutical Inkjet Printing onto Orodispersible Films
Guidelines on patentability and access to medicines
Access to innovative oncology medicines in Europe
Access of high technology medicines in Russia
Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime
Assessment of primary labeling of medicines manufactured by Nepalese pharmaceutical industries
Bioactive proteins and peptides isolated from Chinese medicines with pharmaceutical potential
Strengthening access to medicines through transparency and accountability
Can NGOs regulate medicines markets? Social enterprise in wholesaling, and access to essential medicines
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation